PTX3 and systemic inflammatory response syndrome: In addition, SIRS patients with high levels of PTX3 at admission did have a higher 90-day mortality rate than patients with the 25% lowest levels (Cox regression analysis; hazard ratio 3.0; P = 0.0009) [24].